287 related articles for article (PubMed ID: 25872003)
1. Systematic review and meta-analysis of somatostatin analogues in the prevention of postoperative complication after pancreaticoduodenectomy.
Jin K; Zhou H; Zhang J; Wang W; Sun Y; Ruan C; Hu Z; Wang Y
Dig Surg; 2015; 32(3):196-207. PubMed ID: 25872003
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials.
Li-Ling J; Irving M
Br J Surg; 2001 Feb; 88(2):190-9. PubMed ID: 11167865
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review.
Koti RS; Gurusamy KS; Fusai G; Davidson BR
HPB (Oxford); 2010 Apr; 12(3):155-65. PubMed ID: 20590882
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin analogues for pancreatic surgery.
Gurusamy KS; Koti R; Fusai G; Davidson BR
Cochrane Database Syst Rev; 2012 Jun; (6):CD008370. PubMed ID: 22696379
[TBL] [Abstract][Full Text] [Related]
5. The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials.
Adiamah A; Arif Z; Berti F; Singh S; Laskar N; Gomez D
World J Surg; 2019 Jul; 43(7):1788-1801. PubMed ID: 30798417
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin analogues for pancreatic surgery.
Gurusamy KS; Koti R; Fusai G; Davidson BR
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD008370. PubMed ID: 23633353
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin analogues and the risk of post-operative pancreatic fistulas after pancreatic resection - A systematic review & meta-analysis.
Li T; D'Cruz RT; Lim SY; Shelat VG
Pancreatology; 2020 Mar; 20(2):158-168. PubMed ID: 31980352
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness comparison of prophylactic octreotide and pasireotide for prevention of fistula after pancreatic surgery.
Welsch T; Müssle B; Distler M; Knoth H; Weitz J; Häckl D
Langenbecks Arch Surg; 2016 Nov; 401(7):1027-1035. PubMed ID: 27233242
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials.
Zeng Q; Zhang Q; Han S; Yu Z; Zheng M; Zhou M; Bai J; Jin R
Pancreas; 2008 Jan; 36(1):18-25. PubMed ID: 18192875
[TBL] [Abstract][Full Text] [Related]
10. Octreotide and postoperative pancreatic fistula after pancreaticoduodenectomy: What we know so far? A narrative review.
Tilak M; Tewari M; Shukla HS
Indian J Cancer; 2023; 60(2):152-159. PubMed ID: 37530235
[TBL] [Abstract][Full Text] [Related]
11. [Drug therapy prevention of pancreatic fistula after pancreaticoduodenectomy].
Slim K; Le Borgne J
Ann Chir; 2003 Apr; 128(3):175-6. PubMed ID: 12821085
[No Abstract] [Full Text] [Related]
12. Prospective Evaluation of Pasireotide in Patients Undergoing Pancreaticoduodenectomy: The Washington University Experience.
Dominguez-Rosado I; Fields RC; Woolsey CA; Williams G; Horwedel TA; Rose JB; Hammill CW; Doyle MB; Chapman WC; Strasberg SM; Hawkins WG; Sanford DE
J Am Coll Surg; 2018 Feb; 226(2):147-154.e1. PubMed ID: 29133263
[TBL] [Abstract][Full Text] [Related]
13. Impact of pasireotide on postoperative pancreatic fistulas following distal resections.
Vuorela T; Mustonen H; Kokkola A; Haglund C; Seppanen H
Langenbecks Arch Surg; 2021 May; 406(3):735-742. PubMed ID: 33474568
[TBL] [Abstract][Full Text] [Related]
14. Do somatostatin-analogues have the same impact on postoperative morbidity and pancreatic fistula in patients after pancreaticoduodenectomy and distal pancreatectomy? - A systematic review with meta-analysis of randomized-controlled trials.
Schorn S; Vogel T; Demir IE; Demir E; Safak O; Friess H; Ceyhan GO
Pancreatology; 2020 Dec; 20(8):1770-1778. PubMed ID: 33121847
[TBL] [Abstract][Full Text] [Related]
15. Pasireotide administration after pancreaticoduodenectomy may decrease clinically relevant postoperative pancreatic fistula in high-risk patients with small pancreatic ducts, soft pancreatic parenchyma and cystic or neuroendocrine neoplasia.
Vuorela T; Mustonen H; Kokkola A; Haglund C; Seppänen H
Pancreatology; 2020 Jun; 20(4):757-761. PubMed ID: 32307251
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial.
Kollmar O; Moussavian MR; Richter S; de Roi P; Maurer CA; Schilling MK
Eur J Surg Oncol; 2008 Aug; 34(8):868-875. PubMed ID: 18299182
[TBL] [Abstract][Full Text] [Related]
17. Are somatostatin or its synthetic analogues helpful in reducing pancreatic fistula?
Angst E; Gloor B
Dig Surg; 2012; 29(6):492-3. PubMed ID: 23392316
[No Abstract] [Full Text] [Related]
18. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy.
You DD; Paik KY; Park IY; Yoo YK
Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436
[TBL] [Abstract][Full Text] [Related]
19. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial.
Yeo CJ; Cameron JL; Lillemoe KD; Sauter PK; Coleman J; Sohn TA; Campbell KA; Choti MA
Ann Surg; 2000 Sep; 232(3):419-29. PubMed ID: 10973392
[TBL] [Abstract][Full Text] [Related]
20. Pasireotide is not effective in reducing the development of postoperative pancreatic fistula.
Young S; Sung ML; Lee JA; DiFronzo LA; O'Connor VV
HPB (Oxford); 2018 Sep; 20(9):834-840. PubMed ID: 30060910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
